F3‐03‐03: Disclosure of amyloid status in the a4 trial. (1st July 2015) - Sperling, Reisa A.; Karlawish, Jason; Grill, Joshua D.; Burns, Jeffrey M.; Sultzer, David; Johnson, Keith A.; Aisen, Paul S.